Neuralink launched the first European clinical trial in the UK to test brain implants that let paralyzed patients control ...

Elon Musk's Neuralink is set to conduct a groundbreaking clinical study in Great Britain to test brain chips that allow patients with severe paralysis to control digital tools with their thoughts.

Neuralink is partnering with the University College London Hospitals trust and Newcastle Hospitals to conduct the study.

Elon Musk 's Neuralink is gearing up to conduct a clinical study in UK. The research will explore how its advanced brain chips can help patients with severe paralysis, control digital and physical ...

Neuralink, Elon Musk's brain implant company, is expanding its clinical trials to the UK after its US success. The trials aim ...

Targeted rewriting of the epigenome promises to overcome several challenges in direct gene editing in patient therapies.

A new study reveals that astrocyte-derived GABA, not neuronal activity, plays a central role in PTSD by impairing the brain’s ability to extinguish traumatic memories.

Weight loss medications like Wegovy can be life-changing for people living with obesity or excess weight with related health ...

A Senate committee rejected Trump's proposed 40% cut to NIH funding. Philadelphia's medical research community says it means ...

Harbour BioMed to present phase II data of HBM4003 & tislelizumab combination in MSS metastatic colorectal cancer at ESMO 2025: Cambridge, Massachusetts Friday, August 1, 2025, 18 ...

British patients are set to receive Elon Musk's Neuralink brain chips as part of the first UK clinical trial.

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its proprietary CDH17-targeting antibody-drug conjugate (ADC), 7MW4911, has received ...